MURA

Mural Oncology plc (MURA) | Rumor.io

Mural Oncology

MURA

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about MURA?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% new	0% new	0% 0

Dec 5

Mural Oncology plc ($MURA) has announced the effectiveness of a scheme of arrangement and completion of acquisition by XOMA Royalty Corporation.
The acquisition is expected to be effective on December 5, 2025, with trading of Mural Oncology shares on Nasdaq ceasing on December 4, 2025.
Mural Oncology shareholders will receive $2.035 per share as part of the acquisition, with the company expected to delist and deregister following the completion of the transaction.

Generated by AI

Sentiment

Of the messages about MURA that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	50% -21.23
Bearish	—	—	—	50% +21.23

Bullish· Apr 17

$MURA is expected to have a liquidation value of $5-$8 per share, depending on the pipeline value of its preclinical substances.
The company has a high potential for growth, with preclinical substances targeting cancer potentially worth $10 million to $100 million.
$MURA is likely to be acquired by another company, with some estimates suggesting a buyout price of $4 per share.

Bearish· Apr 16

The company's lack of progress and prospects is highlighted, with some stating it's "going out of business" and others questioning how it can continue to rise.
The company's cash shell status and potential for significant dilution are mentioned, with one post suggesting it's worth $1.25 at best.
The stock's price is expected to drop, with some predicting a sharp decline and others warning of a potential collapse, citing the company's lack of a product and employees.

Generated by AI

Topics

Of the messages about MURA that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	1.4%
Announcements	—	—	—	90.21%
Controversies	—	—	—	1.4%
Earnings	—	—	—	2.8%
Macro	—	—	—	2.8%
Technical Analysis	—	—	—	1.4%

Announcements· Aug 20

Mural Oncology plc ($MURA) has entered into an agreement to be acquired by XRA 5 Corp., a subsidiary of XOMA Royalty, for between $2.035 and $2.24 per share in cash.
The acquisition deal is valued at approximately $36.2 million, with Mural shareholders potentially receiving an additional cash amount of up to $0.205 per share.
The acquisition is expected to close by the end of 2025, with Mural Oncology shares trading higher following the announcement.

Technical Analysis· Apr 15

$MURA has strong support at $1.90 and a possible long gap fill with a 51% upside target.
The stock has completed a 180% push and found slight resistance, with a sustained breakout over the 50-day moving average needed to drive the move.
$MURA is forming resistance at $2.80 and is expected to pull back before the next leg up, with a double top on falling momentum potentially incoming.

Generated by AI

Community

Of the messages about MURA, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	0%	0%	16.75%
Newcomers	100%	100%	100%	83.25%

Aug 20

Mural Oncology plc ($MURA) has announced an agreement to be acquired by XRA 5 Corp., a subsidiary of XOMA Royalty, for between $2.035 and $2.24 per share in cash.
The acquisition is valued at approximately $36.2 million, with Mural shareholders set to receive a base cash price and a potential additional cash amount of up to $0.205 per share.
The acquisition will result in Mural Oncology's shares being halted for trading, with investors awaiting further details on the deal.

Generated by AI

Also Discussed

Investors talking about MURA also mention

#	Name	Attention
1	Sharps Technology Inc.STSS	0%0
2	AREB - American Rebel Holdings, Inc.	——
3	Alkermes plcALKS	0%0
4	UPTD - TradeUP Acquisition Corp.	——
5	ALX Oncology Holdings Inc.ALXO	0%0
6	Apollomics Inc.APLM	0%0
7	Bon Natural Life Ltd. Class A Ordinary SharesBON	0%0
8	FMTO - Femto Technologies Inc.	——
9	Acrivon Therapeutics, Inc.ACRV	0%new
10	Alpha Technology Group Limited Class A Ordinary SharesATGL	0%0

Mural Oncology plc

Location

Social

What share of all stock conversation is about MURA?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% new	0% new	0% 0

Dec 5

Mural Oncology plc ($MURA) has announced the effectiveness of a scheme of arrangement and completion of acquisition by XOMA Royalty Corporation.
The acquisition is expected to be effective on December 5, 2025, with trading of Mural Oncology shares on Nasdaq ceasing on December 4, 2025.
Mural Oncology shareholders will receive $2.035 per share as part of the acquisition, with the company expected to delist and deregister following the completion of the transaction.

Generated by AI

Sentiment

Of the messages about MURA that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	50% -21.23
Bearish	—	—	—	50% +21.23

Bullish· Apr 17

$MURA is expected to have a liquidation value of $5-$8 per share, depending on the pipeline value of its preclinical substances.
The company has a high potential for growth, with preclinical substances targeting cancer potentially worth $10 million to $100 million.
$MURA is likely to be acquired by another company, with some estimates suggesting a buyout price of $4 per share.

Bearish· Apr 16

The company's lack of progress and prospects is highlighted, with some stating it's "going out of business" and others questioning how it can continue to rise.
The company's cash shell status and potential for significant dilution are mentioned, with one post suggesting it's worth $1.25 at best.
The stock's price is expected to drop, with some predicting a sharp decline and others warning of a potential collapse, citing the company's lack of a product and employees.

Generated by AI

Topics

Of the messages about MURA that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	1.4%
Announcements	—	—	—	90.21%
Controversies	—	—	—	1.4%
Earnings	—	—	—	2.8%
Macro	—	—	—	2.8%
Technical Analysis	—	—	—	1.4%

Announcements· Aug 20

Mural Oncology plc ($MURA) has entered into an agreement to be acquired by XRA 5 Corp., a subsidiary of XOMA Royalty, for between $2.035 and $2.24 per share in cash.
The acquisition deal is valued at approximately $36.2 million, with Mural shareholders potentially receiving an additional cash amount of up to $0.205 per share.
The acquisition is expected to close by the end of 2025, with Mural Oncology shares trading higher following the announcement.

Technical Analysis· Apr 15

$MURA has strong support at $1.90 and a possible long gap fill with a 51% upside target.
The stock has completed a 180% push and found slight resistance, with a sustained breakout over the 50-day moving average needed to drive the move.
$MURA is forming resistance at $2.80 and is expected to pull back before the next leg up, with a double top on falling momentum potentially incoming.

Generated by AI

Community

Of the messages about MURA, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	0%	0%	16.75%
Newcomers	100%	100%	100%	83.25%

Aug 20

Mural Oncology plc ($MURA) has announced an agreement to be acquired by XRA 5 Corp., a subsidiary of XOMA Royalty, for between $2.035 and $2.24 per share in cash.
The acquisition is valued at approximately $36.2 million, with Mural shareholders set to receive a base cash price and a potential additional cash amount of up to $0.205 per share.
The acquisition will result in Mural Oncology's shares being halted for trading, with investors awaiting further details on the deal.

Generated by AI

Mural Oncology

Social

Dec 5

Sentiment

Bullish· Apr 17

Bearish· Apr 16

Topics

Announcements· Aug 20

Technical Analysis· Apr 15

Community

Aug 20

Also Discussed

Mural Oncology plc

Company Information

Location

Also Discussed

Social

Dec 5

Sentiment

Bullish· Apr 17

Bearish· Apr 16

Topics

Announcements· Aug 20

Technical Analysis· Apr 15

Community

Aug 20